BioArctic AB
Short position disclosed on July 6, 2026.
0.59% of the capital sold short
1 disclosing fund
201 disclosures on record
SE0010323311 ISIN code
Evolution of the disclosed total
0%0.25%0.5%0.75%1%
Oct 2025Jan 2026Apr 2026Jul 2026
September 3, 2018 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Connor Clark & Lunn Investment Management Ltd. | 0.59% | +0.09 pt | July 6, 2026 |
In the United States BRCTF (OTC): 56,499 shares sold short on September 15, 2026. FINRA names no fund.
On the other side: the funds that hold BioArctic AB Titelia
Get the moves on BioArctic AB by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| September 3, 2018 | Marshall Wace LLP | 0.52% |
Download 201 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 12.10% of the capital sold short
- Elekta AB (publ) 9.31% of the capital sold short
- JM AB 7.21% of the capital sold short
- Bonesupport Holding AB 6.91% of the capital sold short
- Truecaller AB 6.88% of the capital sold short
- Hemnet Group AB (publ) 5.63% of the capital sold short
- Xvivo Perfusion Aktiebolag 5.41% of the capital sold short
- Dynavox Group AB 5.38% of the capital sold short
- RaySearch Laboratories AB (publ) 4.96% of the capital sold short
- Aktiebolaget Electrolux 4.41% of the capital sold short
- AAK AB (publ) 4.31% of the capital sold short
- Hexatronic Group AB 3.77% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, BioArctic AB, source Finansinspektionen, data as at July 6, 2026, https://www.quivad.com/action/bioarctic-ab?page=5